Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Evaluation of neurological improvements in secondary progressive multiple sclerosis patients treated with myeloid targeted immune modulator MIS416
Multiple Sclerosis
P5 - (-)
362
Authors/Disclosures
Gill Webster, PhD
PRESENTER
No disclosure on file
No disclosure on file